Skip to content

Digital Variance Angiography in Diagnostic Angiographies for Effective Radiation Dose Reduction

Application of Digital Variance Angiography in Diagnostic Lower Limb Angiographiy for Radiation Exposure Reduction a Prospective Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04343196
Enrollment
114
Registered
2020-04-13
Start date
2020-04-21
Completion date
2020-10-30
Last updated
2021-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crural Artery Thrombosis, Femoral Artery Occlusion, Femoral Artery Stenosis, Iliac Artery Stenosis, Limb Ischemia, Peripheral Arterial Disease, Peripheral Artery Disease, Popliteal Stenosis

Keywords

Radiation protection, X-ray angiography, Digital Variance Angiography, Digital Subtraction Angiography, Peripheral Arterial Disease, Kinepict, Image acquistion, Image quality, Radiation exposure

Brief summary

Digital Variance Angiography (DVA) is a new tool in medical imaging with proven image quality reserve. The previously observed quality reserve of Digital Variance Angiography (DVA) in lower extremity angiographies, allowed to lower radiation exposure by 70 % during DSA in lower extremity diagnostic angiographies with non-inferior image quality. The aim of this study is to apply this non-inferior image quality and use it for radiation exposure reduction in diagnostic lower limb angiography. The project would prospectively block-randomise (50:50) patients, who undergo elective diagnostic angiography into two groups: a comparator group examined by means of conventional DSA using a standard care protocol (Siemens Artis Zee, Extremities Care setting, 1.2 µGy/frame) (Group B) and a study group examined by means of DVA using a low-dose protocol (0.36 µGy/frame corresponding to 70% decrease of radiation dose) (Group A). During each procedure the investigators record radiation exposure (cumulative dosage, dose area product) and contrast media usage and procedural time then compare the results of the groups. Qualitative image review is done to compare conventional DSA and reduced radiation exposure DVA images after image acquisition. Our hypothesis is that with the previously proven non-inferior image quality, the investigators will be able to reduce radiation exposure of the participants and also staff members in everyday clinical practice.

Interventions

RADIATIONDiagnostic Angiography (DSA or DVA based on randomization result)

After radial/brachial/femoral artery puncture using Seldinger technique, the investigators first position a pigtail catheter above the level of the renal arteries. With Siemens Artis Zee Pure DSA machine the examiner will use a postero-anterior X-ray view for the first image, which is an aortography of some part of the iliac system. Then, the catheter will be repositioned to the aortic bifurcation and 15-18 mL contrast media (CM) with 9-10 mL/s flow for the ilio-femoral region will be injected. All of the following image series will be made from this catheter position, with a 9 mL/s flow rate. In cases for when the recorded image series will be inconclusive, image series with left/right oblique position will be recorded. All femoro-popliteal images will be recorded with 10-16 ml CM and crural regions with 12-22mml. DSA images will be calculated from all series on a dedicated Syngo workstation and used for diagnosis. DVA images will be calculated by the Kinepict Medical Imaging Tool

Sponsors

Semmelweis University Heart and Vascular Center
CollaboratorOTHER
Kinepict Health Ltd.
Lead SponsorNETWORK

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

All enrolled participants will undergo a diagnostic lower limb angiography, but the image acquisition protocol will be different. In the active comparator group a normal radiation dose will be used and the DSA images will be used for diagnosis whereas in the experimental group a low dose radiation will be applied (70% decrease compared tot he DSA protocol) and the DVA images will be used for diagnosis.

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Patients with lower limb peripheral arterial disease, admitted for diagnostic angiography * Fontaine II- IV * Normal renal function: GFR\> 60ml/min/m2 * Age \> 18

Exclusion criteria

* Acute myocardial infarction * Severe heart/liver/renal failure * Iodine contrast allergy * Atrioventricular block * Coagulopathy and Hematological Bleeding Disorders

Design outcomes

Primary

MeasureTime frameDescription
Total procedural Dose-area product(DAP)During the procedureIndicator of a patient's irradiation dosage (microGy\*cm2 or Gy\*cm2)
Total DSA-related DAPDuring the procedureRadiation load of the patient during DSA image acquistion (microGy\*cm2 or Gy\*cm2)
Image quality reviewUpon completion of enrollment, approximately 1-year periodBlinded, anonymised and randomised qualitative review and comparison of images by multiple endovascular specialists in multiple regions using a 1-5 Likert-scale for each image. Region specific scores are compared between DSA and DVA technique.
TASC classificationUpon completion of enrollment, approximately 1-year periodBlinded, anonymised and randomised review of images by multiple endovascular specialists. Clinically relevant sides for each patient are reviewed in a separate questionnaire: each reviewer have to classify each patient's angiographic image according to the Trans-Atlantic Inter-Society Consensus Document's second version.

Secondary

MeasureTime frameDescription
Number of protocol changeDuring the procedureThe number of occasions when the reduced radiation level protocol has to be switched back to conventional protocol in one region because of unsuitable image quality.
Procedure timeDuring the procedureDuration of the whole procedure, from radial artery puncture till the removal of every tool (min).
Contrast media usageDuring the procedureThe volume of the iodinated contrast agent used for enhancing the image quality (mL)

Countries

Hungary

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026